Accueil   Calls for projects   Joint Translational Call for “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

Joint Translational Call for “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”

Joint Translational Call for “Multinational research projects on Personalised Medicine for Neurodegenerative Diseases” - JTC 2019

Key features of the call for projects

Type de l'appel : Collaboratif

Date de clôture : March 12th, 2019

Dimension : Europe

Funding:

Appel d'offre thématisé

Thématique(s) médicale(s) : CNS-related diseases

Secteur(s) industriel(s) :

The ANR launches in collaboration with the ERA-NET JPcofuND  2 a joint call to support multinational, collaborative research projects addressing the Personalised Medicine for Neurodegenerative Diseases. More than €30 million have already been earmarked by JPND member countries and the European Commission for this action.

The present call is supported by 24 member countries: Australia, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Turkey and United Kingdom.

The aim of the call is to finance ambitious, innovative, multinational and multidisciplinary projects that address precision medicine approaches for the neurodegenerative diseases.

 

Details here:

 

Contact:

Dr. Sheyla Mejia-Gervacio
sheyla.mejia@anr.fr
+ 33 1 78 09 80 14

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree